Literature DB >> 19362056

Apoptosis and colorectal cancer: implications for therapy.

Shi Yu Yang1, Kevin M Sales, Barry Fuller, Alexander M Seifalian, Marc C Winslet.   

Abstract

Colorectal cancer (CRC) is characterized by the partial suppression of apoptosis, which in turn gives tumours a selective advantage for survival and can cause current chemotherapy approaches to be ineffective. Recent progress in understanding the mechanisms of apoptosis in colorectal carcinogenesis has provided potential new targets for therapy. Here, we review recent studies of the regulation of apoptosis and its role in CRC initiation and progression, and we discuss the relationship between chemoresistance and the suppression of apoptosis. Recent progress in targeting apoptotic pathways and their regulators provide strategies for the exploration of novel therapies for CRC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19362056     DOI: 10.1016/j.molmed.2009.03.003

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  31 in total

1.  The igf system in carcinogenesis and its implication for cancer therapy.

Authors:  S Y Yang; M Winslet
Journal:  Curr Oncol       Date:  2011-12       Impact factor: 3.677

2.  NOB1 is essential for the survival of RKO colorectal cancer cells.

Authors:  Xiao-Wen He; Tao Feng; Qiao-Ling Yin; Yuan-Wei Jian; Ting Liu
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

3.  Simulated colon fiber metabolome regulates genes involved in cell cycle, apoptosis, and energy metabolism in human colon cancer cells.

Authors:  Heli Putaala; Harri Mäkivuokko; Kirsti Tiihonen; Nina Rautonen
Journal:  Mol Cell Biochem       Date:  2011-06-11       Impact factor: 3.396

4.  An ornamental plant targets epigenetic signaling to block cancer stem cell-driven colon carcinogenesis.

Authors:  Ishfaq Ahmed; Badal C Roy; Dharmalingam Subramaniam; Showkat Ahmad Ganie; Deep Kwatra; Dan Dixon; Shrikant Anant; Mohammad Afzal Zargar; Shahid Umar
Journal:  Carcinogenesis       Date:  2016-01-19       Impact factor: 4.944

5.  ABT-737 overcomes resistance to immunotoxin-mediated apoptosis and enhances the delivery of pseudomonas exotoxin-based proteins to the cell cytosol.

Authors:  Roberta Traini; Gal Ben-Josef; Diana V Pastrana; Elizabeth Moskatel; Ashima K Sharma; Antonella Antignani; David J Fitzgerald
Journal:  Mol Cancer Ther       Date:  2010-06-29       Impact factor: 6.261

6.  Differential control of growth, apoptotic activity and gene expression in human colon cancer cells by extracts derived from medicinal herbs, Rhazya stricta and Zingiber officinale and their combination.

Authors:  Ayman I Elkady; Rania Abd El Hamid Hussein; Osama A Abu-Zinadah
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

7.  COX-2-independent induction of apoptosis by celecoxib and polyamine naphthalimide conjugate mediated by polyamine depression in colorectal cancer cell lines.

Authors:  Song-qiang Xie; Ya-hong Zhang; Qian Li; Jian-hong Wang; Jing-hua Li; Jin Zhao; Chao-jie Wang
Journal:  Int J Colorectal Dis       Date:  2011-12-10       Impact factor: 2.571

8.  Helical repeat structure of apoptosis inhibitor 5 reveals protein-protein interaction modules.

Authors:  Byeong-Gu Han; Kyoung Hoon Kim; Sang Jae Lee; Kyung-Chae Jeong; Jea-Won Cho; Kyung Hee Noh; Tae Woo Kim; Soon-Jong Kim; Hye-Jin Yoon; Se Won Suh; Sangho Lee; Byung Il Lee
Journal:  J Biol Chem       Date:  2012-02-12       Impact factor: 5.157

9.  The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells.

Authors:  A Greenhough; C A Wallam; D J Hicks; M Moorghen; A C Williams; C Paraskeva
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

10.  IGF2 knockdown in two colorectal cancer cell lines decreases survival, adhesion and modulates survival-associated genes.

Authors:  Michael A Rogers; Verena Kalter; Moritz Strowitzki; Martin Schneider; Peter Lichter
Journal:  Tumour Biol       Date:  2016-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.